Log In
BCIQ
Print this Print this
 

Sci-B-Vac

  Manage Alerts
Collapse Summary General Information
Company VBI Vaccines Inc.
DescriptionHBV vaccine containing the S, preS1 and preS2 surface antigens
Molecular Target
Mechanism of Action 
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentMarketed
Standard IndicationHepatitis B virus (HBV)
Indication DetailsPrevent hepatitis B virus (HBV) infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/09/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today